Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab-Reference-Cited by-同舟云学术

Markers for EGFR pathway activation as predictor of outcome in metastatic colorectal cancer patients treated with or without cetuximab

Published:2010-07 Issue:11 Volume:46 Page:1997-2009
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Tol Jolien,Dijkstra Jeroen R.,Klomp Marjolein,Teerenstra Steven,Dommerholt Martin,Vink-Börger M. Elisa,van Cleef Patricia H.,van Krieken J. Han,Punt Cornelis J.A.,Nagtegaal Iris D.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference42 articles.

1. Treatment in advanced colorectal cancer: what, when and how?;Chau;Br J Cancer,2009

2. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

3. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial;Kabbinavar;J Clin Oncol,2005

4. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study;Saltz;J Clin Oncol,2008

5. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer;Cunningham;N Engl J Med,2004

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis;BMC Cancer;2023-11-16

2. Expression Profile of KRAS and p16 in Periampullary Cancer;Indian Journal of Surgical Oncology;2023-09-15

3. A study of gene variation in All-RAS wild-type metastatic colorectal cancer and its correlation with cetuximab;Journal of Gastrointestinal Oncology;2022-12

4. Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancer;BMC Cancer;2022-04-12

5. Objective quantitation of EGFR protein levels using Quantitative Dot Blot (QDB) method for prognosis of gastric cancer patients;2021-04-15